The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Revising Fibromyalgia: One Year Later

Revising Fibromyalgia: One Year Later

July 12, 2011 • By Heather Haley

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Personally important to Dr. Wolfe, the 2010 criteria accommodate a spectrum of beliefs regarding the legitimacy of fibromyalgia as a diagnosis. “The new criteria enable physicians who are uncomfortable with the socio-political aspect of fibromyalgia to evaluate patients without having to sign in as a full-time believer in fibromyalgia. Instead of saying, ‘We’re treating fibromyalgia,’ we have patients who have with high levels of fatigue, sleep disturbance, and body pain. We are treating those symptoms.”

You Might Also Like
  • Is Fibromyalgia Overdiagnosed?
  • Many Doctors & Specialists Don’t Adhere to Fibromyalgia Diagnostic Criteria
  • Rheumatology Coding Corner Question: Trigger-Point Injections for Fibromyalgia
Explore This Issue
July 2011

Criticisms of the 2010 Criteria

The two primary criticisms of the revised criteria are the removal of the tender point exam and the exclusion of depression from the symptom severity scale. “The new criteria have been misconstrued as saying doctors no longer need to do a physical examination to diagnose fibromyalgia,” says Dr. Goldenberg. “In the 2010 criteria, we explicitly state the need rule out other conditions. In the old criteria, excluding other conditions was only implicitly stated. It’s impossible to determine if someone has a musculoskeletal disorder versus fibromyalgia without touching them. With the new criteria, what we are saying is that 11 of 18 tender points are not necessary to make an accurate diagnosis of fibromyalgia.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Many in the rheumatology community were displeased at the exclusion of depression from the 2010 fibromyalgia criteria. “The reality is we don’t see happy, healthy people in rheumatology practice. High rates of depression are seen across all chronic diseases including osteoarthritis, lupus, and rheumatoid arthritis,” says Dr. Wolfe. “Depression was excluded because it didn’t improve the specificity for diagnosing fibromyalgia.”

Psychiatrists generally support the decision to exclude depression from fibromyalgia diagnostic criteria. “Given [that] we’re focused on specificity over sensitivity, including depression would not help us to make a more accurate diagnosis for fibromyalgia,” says Rakesh Jain MD, MPH, practicing psychiatrist and clinical researcher from Lake Jackson, Texas. Although depression is not helpful in making an accurate fibromyalgia diagnosis, the committee widely acknowledges depression is still a significant clinical presentation for fibromyalgia. As Dr. Wolfe notes, “depression and fibromyalgia is a chicken–egg scenario. We cannot differentiate if depression is the result of fibromyalgia symptoms or if one cannot have fibromyalgia without depression.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The tender point exam did not emphasize the major features of fibromyalgia such as the extent of the pain, fatigue, sleep disturbance, multiple somatic symptoms, and cognitive difficulties.

—Frederick Wolfe, MD

Clinical Utility of the 2010 Criteria

The 2010 ACR criteria with the widespread pain index and symptom severity score have the clinical potential to serve as both a screening tool and a patient management tool. Dr. Clauw would like to see rheumatology and leaders in fibromyalgia position the new criteria as screening criteria for fibromyalgia. Specific to the rheumatology practice, screening is relevant for patients with rheumatoid arthritis, osteoarthritis, and lupus, who have a higher prevalence of fibromyalgia.

Pages: 1 2 3 4 5 6 | Single Page

Filed Under: Conditions, Practice Management, Soft Tissue Pain Tagged With: AC&R, Diagnostic Criteria, Evaluation and Management, Fibromyalgia, Guidelines, patient careIssue: July 2011

You Might Also Like:
  • Is Fibromyalgia Overdiagnosed?
  • Many Doctors & Specialists Don’t Adhere to Fibromyalgia Diagnostic Criteria
  • Rheumatology Coding Corner Question: Trigger-Point Injections for Fibromyalgia
  • Audioconference: Management of Fibromyalgia

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.